• 1
    Schnitzer T, Gray W, Paster Z, Kamin M. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000; 27: 7728.
  • 2
    Hart L, Deyo R, Cherkin D. Physician office visits for low back pain. Spine 1995; 20: 1119.
  • 3
    Portenoy RK. Opioid therapy for chronic nonmalignant pain: current status. In: FieldsHL, LiebeskindJC, editors. Progress in pain research and management. Seattle: International Association for the Study of Pain; 1994. p. 24787.
  • 4
    Murphy TM. Chronic opioids for chronic low back pain: solution or problem? J Am Board Fam Pract 1996; 9: 2257.
  • 5
    Haythornwaite J, Menefee L, Quatrano-Piacentini A, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998; 15: 18594.
  • 6
    Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995; 62: 16978.
  • 7
    Haugen PS. Prescribing opiates for pain relief. Minn Med 2000; 83: 5762.
  • 8
    Shapiro RS. Health care providers' liability exposure for inappropriate pain management. J Law Med Ethics 1996; 24: 3604.
  • 9
    Pappagallo M, Campbell JN. The pharmacologic management of chronic back pain. In: FrymoyerJW, editor. The adult spine: principles and practice. Philadelphia: Lippincott-Raven; 1997. p. 27585.
  • 10
    Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993; 8: 27988.
  • 11
    Schofferman J. Long-term opioid analgesic therapy for severe refractory lumbar spine pain. Clin J Pain 1999; 15: 13640.
  • 12
    Schug SA, Zech D, Grond S, Jung H, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992; 7: 25966.
  • 13
    Portenoy RK. Pain and quality of life: theoretical aspects. In: OsobaD, editor. Quality of life in cancer patients. New York: CRC Publishers; 1991. p. 27992.
  • 14
    Foley KM. Clinical tolerance to opioids. In: BasbaumIA, BessonJM, editors. Towards a new pharmacotherapy of pain. Chichester (UK): John Wiley & Sons; 1991. p. 181203.
  • 15
    Perry S, Heidrich G. Management of pain during debridement: a survey of US burn units. Pain 1980; 13: 26780.
  • 16
    Brookoff D, Palmano R. Treating sickle cell pain like cancer pain. Ann Intern Med 1992; 116: 3648.
  • 17
    Walters A, Winkelman J, Trenkwalder C, Fry J, Kataria V, Wagner M, et al. Long term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16: 11059.
  • 18
    Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998; 41: 160312.
  • 19
    Caldwell JR, Rapaport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002; 23: 27891.
  • 20
    Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 183741.
  • 21
    Brown RL, Fleming MF, Patterson JJ. Chronic opioid analgesic therapy for chronic low back pain. J Am Board Fam Pract 1996; 9: 191204.
  • 22
    American Academy of Pain Medicine, American Pain Society. The use of opioids for the treatment of chronic pain. Glenville (IL): American Academy of Pain Medicine, American Pain Society; 1996.
  • 23
    Katz D, Baptista J, Azen SP, Pile MC. Obtaining confidence intervals for the risk ration in cohort studies. Biometrics 1978; 34: 46974.
  • 24
    Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 14958.
  • 25
    Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med 1996; 335: 112431.
  • 26
    Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 1994; 59: 2018.
  • 27
    Van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2003; 1: 157.
  • 28
    Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992; 7: 6977.
  • 29
    Portenoy RK. Opioid therapy in the management of chronic back pain. In: TollisonCD, editor. Interdisciplinary rehabilitation of low back pain. Baltimore: Williams & Wilkins; 1989. p. 13757.
  • 30
    Jamison R, Anderson K, Peeters-Asdourian C, Ferrante F. Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth 1994; 19: 22530.
  • 31
    Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998; 23: 2591600.
  • 32
    Hale ME, Fleischmann R, Salzman R, Wild J, Iwan T, Swanton RE, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain 1999; 15: 17983.
  • 33
    Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial or oral morphine for chronic non-cancer pain. Lancet 1996; 347: 1437.
  • 34
    Way EL. Opioid tolerance and physical dependence and their relationship. In: HerzA, editor. Opioids II: handbook of experimental pharmacology. New York: Springer Verlag; 1993. p. 57395.
  • 35
    Colpaert FC. Mechanisms of opioid-induced pain and antinociceptive tolerance: signal transduction. Pain 2002; 95: 2878.
  • 36
    Colpaert FC, Niemegeers CJ, Janssen PA, Maroli AN. The effects of prior fentanyl administrations and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. J Pharmacol Exp Ther 1980; 213: 41824.
  • 37
    Colpaert FC, Tarayre JP, Alliaga M, Bruins Slot LA, Attal N, Koek W. Opiate self-administration as a measure of chronic nociceptive pain in arthritis rats. Pain 2001; 91: 3345.
  • 38
    Foley KM. Changing concepts of tolerance to opioids: what the cancer patient has taught us. In: ChapmanCR, FoleyKM, editors. Current and emerging issues in cancer pain: research and practice. New York: Raven Press; 1993. p. 33150.
  • 39
    Taub A. Opioid analgesics in the treatment of chronic intractable pain on non-neoplastic origin. In: KitahataLM, CollinsD, editors. Narcotic analgesics in anaesthesiology. Baltimore: Williams & Wilkins; 1982. p. 199208.
  • 40
    Tennant FS, Uelmen GF. Narcotic maintenance for chronic pain: medical and legal guidelines. J Postgrad Med 1983; 73: 8194.
  • 41
    France RD, Urban BJ, Keefe FJ. Long term use of narcotic analgesics in chronic pain. Soc Sci Med 1984; 19: 137982.
  • 42
    Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25: 17186.
  • 43
    Shannon CN, Baranowski AP. Use of opioids in non-cancer pain. Br J Hosp Med 1997; 58: 45963.
  • 44
    Pappagallo M. Aggressive pharmacologic treatment of pain. Rheum Dis Clin North Am 1999; 25: 193212.
  • 45
    Gimble JS, Richards P, Portenoy RK. Controlled release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003; 60: 92734.
  • 46
    Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000; 27: 76471.
  • 47
    Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346: 66770.
  • 48
    Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 87383.
  • 49
    Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002; 17: 1739.
  • 50
    Miotto K, Compton P, Ling W, Conolly M. Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996; 37: 22335.
  • 51
    Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997; 13: 1505.
  • 52
    Brown RL, Patterson JJ, Rounds LA, Papasouliotis O. Substance abuse among patients with chronic back pain. J Fam Pract 1996; 43: 15260.
  • 53
    Portenoy RK, Dole V, Joseph H, Lowinson J, Rice C, Segal S, et al. Pain management and chemical dependency: evolving perspectives. JAMA 1997; 278: 5923.
  • 54
    Benson K, Hartz A. A comparison of observational studies and randomized controlled trials. N Engl J Med 2000; 342: 187886.
  • 55
    Concato J, Shah N, Horwitz R. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 188792.
  • 56
    Pocock S, Elbourne D. Randomized trials or observational tribulations? N Engl J Med 2000; 342: 19079.
  • 57
    Jensen M, Karoly P. Self-report scales and procedures for assessing pain in adults. New York: The Guilford Press; 1992.
  • 58
    Pappagallo M, Heinberg LJ. Ethical issues in the management of chronic nonmalignant pain. Semin Neurol 1997; 17: 20311.
  • 59
    Clark HW, Sees KL. Opioids, chronic pain and the law. J Pain Symptom Manage 1993; 8: 297305.